GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » J Frontier Co Ltd (TSE:2934) » Definitions » EBIT

J Frontier Co (TSE:2934) EBIT : 円-1,432 Mil (TTM As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is J Frontier Co EBIT?

J Frontier Co's earnings before interest and taxes (EBIT) for the three months ended in Feb. 2024 was 円-103 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2024 was 円-1,432 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. J Frontier Co's annualized ROC % for the quarter that ended in Feb. 2024 was -9.96%. J Frontier Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2024 was -19.73%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. J Frontier Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2024 was -10.90%.


J Frontier Co EBIT Historical Data

The historical data trend for J Frontier Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J Frontier Co EBIT Chart

J Frontier Co Annual Data
Trend May19 May20 May21 May22 May23
EBIT
112.80 136.44 679.66 701.88 -1,835.75

J Frontier Co Quarterly Data
May19 May20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -331.11 -1,107.01 36.29 -258.98 -102.50

Competitive Comparison of J Frontier Co's EBIT

For the Pharmaceutical Retailers subindustry, J Frontier Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


J Frontier Co's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, J Frontier Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where J Frontier Co's EV-to-EBIT falls into.



J Frontier Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1,432 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


J Frontier Co  (TSE:2934) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

J Frontier Co's annualized ROC % for the quarter that ended in Feb. 2024 is calculated as:

ROC % (Q: Feb. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Nov. 2023 ) + Invested Capital (Q: Feb. 2024 ))/ count )
=-440.608 * ( 1 - -15.11% )/( (4704.154 + 5484.393)/ 2 )
=-507.1838688/5094.2735
=-9.96 %

where

Invested Capital(Q: Nov. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7359.948 - 1345.505 - ( 1310.289 - max(0, 2545.296 - 4663.806+1310.289))
=4704.154

Invested Capital(Q: Feb. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8659.929 - 1992.431 - ( 1183.105 - max(0, 3896.23 - 5386.638+1183.105))
=5484.393

Note: The Operating Income data used here is four times the quarterly (Feb. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

J Frontier Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Feb. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2023  Q: Feb. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-410.016/( ( (284.633 + max(1702.542, 0)) + (337.26 + max(1830.953, 0)) )/ 2 )
=-410.016/( ( 1987.175 + 2168.213 )/ 2 )
=-410.016/2077.694
=-19.73 %

where Working Capital is:

Working Capital(Q: Nov. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1559.958 + 1499.054 + 294.505) - (1345.505 + 0 + 305.47)
=1702.542

Working Capital(Q: Feb. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2228.132 + 1624.357 + 351.044) - (1992.431 + 0 + 380.149)
=1830.953

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Feb. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

J Frontier Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Feb. 2024 )
=-1432.2/13144.168
=-10.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


J Frontier Co EBIT Related Terms

Thank you for viewing the detailed overview of J Frontier Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


J Frontier Co (TSE:2934) Business Description

Traded in Other Exchanges
Address
2-9-9 Shibuya, SANWA Aoyama Building, 8th floor, Shibuya-ku, Tokyo, JPN, 150-0002
J Frontier Co Ltd is engaged in the healthcare sales business, medical care sales business and healthcare marketing business.

J Frontier Co (TSE:2934) Headlines

No Headlines